<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Decreased cerebral blood flow causes <z:hpo ids='HP_0100543'>cognitive impairments</z:hpo> and neuronal injury in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we reported that <z:chebi fb="0" ids="53289,53290,53292">donepezil</z:chebi>, a <z:chebi fb="0" ids="37733">cholinesterase inhibitor</z:chebi>, improved transient global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-induced spatial <z:hpo ids='HP_0002354'>memory impairment</z:hpo> in gerbils </plain></SENT>
<SENT sid="2" pm="."><plain>Treatment with 5mg/kg of <z:chebi fb="0" ids="53289,53290,53292">donepezil</z:chebi> for 21 consecutive days following a 10-min period of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> significantly inhibited delayed neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in the hippocampal CA1 region </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:mp ids='MP_0001465'>Morris water maze</z:mp> test, <z:hpo ids='HP_0002354'>memory impairment</z:hpo> was significantly improved by <z:chebi fb="0" ids="53289,53290,53292">donepezil</z:chebi> treatment </plain></SENT>
<SENT sid="4" pm="."><plain>Western blot analysis showed that <z:chebi fb="0" ids="53289,53290,53292">donepezil</z:chebi> treatment prevented reductions in p-CaMKII and p-CREB protein levels in the hippocampus </plain></SENT>
<SENT sid="5" pm="."><plain>These results suggest that <z:chebi fb="0" ids="53289,53290,53292">donepezil</z:chebi> attenuates the <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficit</z:e> induced by transient global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and this neuroprotection may be associated with the phosphorylation of CaMKII and CERB in the hippocampus </plain></SENT>
</text></document>